Vesilute Peptide (20mg)
Vesilute Peptide (20mg) view 1
Vesilute Peptide (20mg) view 2
Bioregulator Vials
Verified Quality

Vesilute Peptide (20mg)

4.88 (34 Reviews)
Ships worldwide
$84.97

Sales Tax included at checkout

Laboratory Research Chemical • Scroll down for full specifications

1

Priority Shipping

Fast & Discreet

99% Purity

HPLC Verified

Full Refund

60-Day Promise

Lab Synthesis

GMP Certified

Product Information

Detailed laboratory specifications, compound structure, and research applications.

Research Grade

HPLC 99%+ Purity

Verified Origin

GMP Manufactured

Vesilute Peptide Description

Vesilut functions as a Khavinson peptide bioregulator designed for laboratory research use in urinary system studies. This Glu-Asp dipeptide enables researchers to investigate cellular regulation mechanisms affecting bladder function and prostate tissues through in vitro applications.

Laboratory studies examine how this bioregulator peptide interacts with smooth muscle function, blood flow regulation, and biochemical processes linked to chronic cystitis, benign prostatic hyperplasia, and prostatitis research models. Vesilute offers research teams high-purity material for studying urinary tract cellular dynamics and prostate gland regulatory pathways.

Peptide Information

Property Value
Peptide Sequence H-Glu-Asp-OH
Molecular Formula C₉H₁₄N₂O₇
Molecular Weight 262.20 g/mol
CAS Number 3918-84-1
PubChem CID 99716

Research Chemical Disclaimer

This product is intended for laboratory research use only. It is not for human consumption, diagnostic, or therapeutic purposes. Handling should only be performed by qualified professionals.

Complete Your Research

Synergistic compounds from the Bioregulator Vials lineup

View Full Collection
Regeno Blend (BPC-157, TB-500, Cartalax) 30mg

Regeno Blend (BPC-157, TB-500, Cartalax) 30mg

Peptide Blend Description

This 30mg research blend delivers three complementary peptides in a single vial: BPC-157, TB-500, and Cartalax. Each component contributes distinct mechanisms for laboratory research. BPC-157 (10mg) targets gastric-derived pathways. TB-500 (10mg) provides the 43-amino acid thymosin beta-4 sequence. Cartalax (10mg) offers the bioregulatory AED tripeptide.

Manufactured in USA facilities under pharmaceutical-grade standards with third-party testing verification. Supplied as sterile lyophilized powder at ≥99% purity. Designed for researchers studying connective tissue mechanisms, cellular repair pathways, and fibroblast activity in controlled laboratory settings. For in vitro research applications only.

Product Specifications

Specification BPC-157 TB-500 (Thymosin Beta-4) Cartalax (AED)
Sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser Ala-Glu-Asp
Molecular Formula C62H98N16O22 C212H350N56O78S C12H19N3O8
Molecular Weight 1419.5 g/mol 4963.4 g/mol 333.29 g/mol
CAS Number 137525-51-0 77591-33-4 205640-90-0
PubChem CID 9941957 16132341 87815447
Synonyms Bepecin, Bpc 15, Body protection compound 15, Pentadecapeptide Thymosin Beta 4, Thymosin β4, TB500, Timbetasin T-31, AED, Alanyl-glutamyl-aspartic acid

Product Usage:

This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only.  This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug.

$279.97

Research Specification

Comprehensive documentation for laboratory application and compound verification.

HPLC Verification

Purity levels exceeding 99.2% guaranteed via third-party high-performance liquid chromatography testing.

Storage Compliance

Stored at -20°C in oxygen-free environment. Shipped with cold-chain monitoring protocols.

CAS Registry

Uniquely identified compound with full structural validation and mass spectrometry reports.

Usage Policy

Strictly for lab research. Not for human or therapeutic use. Waiver required for bulk orders.